The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Pocock, S. J., & Simon, R. (1975) · Biometrics · doi:10.2307/2529712 · Cited by 2,350
Herskovic, A., Martz, K., Al-Sarraf, M., Leichman, L., Brindle, J., Vaitkevicius, V., Cooper, J., Byhardt, R., Davis, L., & Emami, B. (1992) · New England Journal of Medicine · doi:10.1056/nejm199206113262403 · Cited by 2,108
The Thrombogenic Effect of Anticancer Drug Therapy in Women with Stage II Breast Cancer
Levine, M. N., Gent, M., Hirsh, J., Arnold, A., Goodyear, M. D., Hryniuk, W., & De Pauw, S. (1988) · New England Journal of Medicine · doi:10.1056/nejm198802183180703 · Cited by 412
Activity of Taxol in Patients With Squamous Cell Carcinoma and Adenocarcinoma of the Esophagus
Ajani, J. A., Ilson, D. H., Daugherty, K., Pazdur, R., Lynch, P. M., & Kelsen, D. P. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.14.1086 · Cited by 280
Kelsen, D. P., Minsky, B. D., Smith, M. J., Beitler, J. J., Niedzwiecki, D., Chapman, D. S., Bains, M. S., BURT, M. E., Heelan, R. T., & Hilaris, B. S. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.8.1352 · Cited by 152
(2003) · Current Problems in Cancer · doi:10.1016/s0147-0272(03)00106-5 · Cited by 126
Chemotherapy in Esophageal Cancer
Kelsen, D. P. (2023) · Frontiers research topics · doi:10.3389/978-2-8325-4252-1 · Cited by 87
Heparin abolishes the chemotherapy-induced increase in plasma fibrinopeptide A levels
Edwards, R. L., Klaus, M., Matthews, E., et al. (1990) · The American Journal of Medicine · doi:10.1016/0002-9343(90)90093-s · Cited by 64
Cited by
Enzinger, P. C., & Mayer, R. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmra035010 · Cited by 2,509
Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma
Doki, Y., Ajani, J. A., Kato, K., Xu, J., Wyrwicz, L., Motoyama, S., Ogata, T., Kawakami, H., Hsu, C.-H., Adenis, A., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2111380 · Cited by 1,230
Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Obermannová, R., Alsina, M., Cervantes, A., Leong, T., Lordick, F., Nilsson, M., van Grieken, N. C. T., Vogel, A., & Smyth, E. C. (2022) · Annals of Oncology · doi:10.1016/j.annonc.2022.07.003 · Cited by 730
Esophageal cancer practice guidelines 2017 edited by the Japan esophageal society: part 2
Kitagawa, Y., Uno, T., Oyama, T., Kato, K., Kato, H., Kawakubo, H., Kawamura, O., Kusano, M., Kuwano, H., Takeuchi, H., et al. (2019) · Esophagus · doi:10.1007/s10388-018-0642-8 · Cited by 569
Esophageal cancer practice guidelines 2017 edited by the Japan Esophageal Society: part 1
Kitagawa, Y., Uno, T., Oyama, T., Kato, K., Kato, H., Kawakubo, H., Kawamura, O., Kusano, M., Kuwano, H., Takeuchi, H., et al. (2019) · Esophagus · doi:10.1007/s10388-018-0641-9 · Cited by 519
Metadata
- Authors
- Bleiberg, H., Conroy, T., Paillot, B., Lacave, A. J., Blijham, G., Jacob, J. H., Bedenne, L., Namer, M., De Besi, P., Gay, F., Collette, L., & Sahmoud, T.
- Venue
- European Journal of Cancer
- Publisher
- Elsevier BV
- Published
- 1997-07
- Volume
- 33
- Issue
- 8
- Pages
- 1216-1220
- ISSN
- 0959-8049 (ISSN-L)
- OpenAlex
- W2027298808
- Cited by
- 349
- References
- 12
- FWCI
- 4.26
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancer. https://app.cochat.ai/papers/10.1016/s0959-8049(97)00088-9
- The paper
- Bleiberg, H., Conroy, T., Paillot, B., Lacave, A. J., Blijham, G., Jacob, J. H., Bedenne, L., Namer, M., De Besi, P., Gay, F., Collette, L., & Sahmoud, T. (1997). Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancer. European Journal of Cancer. https://doi.org/10.1016/s0959-8049(97)00088-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.